Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2005
12/22/2005US20050281824 Methods of using IMXP-888 and IMXP-888 antagonists
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050281793 T cell activation
12/22/2005CA2569137A1 Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides
12/22/2005CA2565124A1 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/21/2005EP1607399A2 BIS-(N,N'-BIS-(2-Haloethyl)Amino) Phosphoramidates as antitumor agents
12/21/2005EP1607101A1 Degradation inhibitor for hepatitis b virus x interacting protein
12/21/2005EP1607091A1 Antihepatitis c virus agent and anti-hiv agent
12/21/2005EP1606319A2 Treatment of viral infections
12/21/2005EP1606318A2 Improved fc fusion proteins
12/21/2005EP1606314A2 Fc REGION VARIANTS
12/21/2005EP1606260A1 Oxamide derivatives useful as raf-kinase inhibitors
12/21/2005EP1605943A2 1-amino 1h-imidazoquinolines
12/21/2005EP1605942A1 Regimen of administration for nelfinavir
12/21/2005EP1605938A2 Antibacterial agents
12/21/2005EP1605927A1 Anti-microbially active diamine-based guanine derivatives
12/21/2005EP1605918A2 Novel galenical system for active transport, method for preparation and use
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1468075B1 Novel lactobacillus sp. strain and use thereof
12/21/2005EP1465898B1 Biocidal compounds and their preparation
12/21/2005EP1429780B1 Method of treating middle ear infections
12/21/2005EP1404852B1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
12/21/2005EP1402267B1 Chp for use as marker for sepsis
12/21/2005EP1379547B1 Modified cyclosporin as a pro-drug and use thereof as a medicament
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1313738B1 Process for the preparation and purification of thiol-containing maytansinoids
12/21/2005EP1307445B1 Benzofuran derivatives and their use as antibacterial agents
12/21/2005EP1278759B1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1261625B1 Memno peptides, a process for their preparation and their use
12/21/2005EP1228097B1 Antimicrobial activity of the first cationic cluster of human lactoferrin
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1222200B1 Fusion protein between HPV-L1 and a peptide, capable of forming a VLP and that functions as a vehicle for introduction of a peptide in a cell and medical uses thereof
12/21/2005EP1104436B1 Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b virus
12/21/2005CN1711277A Substituted 9a-N-[N'-(benzenesulfonyl)carbamoyl-gamma-aminopropyl] and 9a-N-[N'-(beta-cyaneothyl)-N'-(benzenesulfonyl)carbamoyl-gamma-aminopropyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithr
12/21/2005CN1232641C Modulator for function of receptor of TNF/NGF receptor family and other protein
12/21/2005CN1232539C Match of organic medicine and beta-cyclodextrin derivative and its preparing process
12/21/2005CN1232527C Method used for transforming the carbonyl function in position 4
12/21/2005CN1232507C Growth hormone secretagogues
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232310C Implanted body for being as regenerated vertebration and tubular bone
12/21/2005CN1232302C Compound preparation of Azithromycin and Pidotimod
12/21/2005CN1232301C Compound preparation of valvciclovir HCL and Pidotimod
12/21/2005CN1232300C Left ofloxacin and Pidotimod compound preparation
12/21/2005CN1232295C White flagger oral liquid and its preparing method
12/21/2005CN1232288C Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process
12/21/2005CN1232280C Medicine composition for anti-virus treating SARS
12/21/2005CN1232259C Medicine composition with two-way immune regulation function by oral cavity local administration
12/21/2005CN1232258C Anti-infection medicine
12/21/2005CN1232257C Application of N-acetylglucosamine in the preparation of medicine for treating and controlling non specific inflammation due to physicochemical factor
12/21/2005CN1232252C Retard release preparation containing alpha-lipoic acid (derivatives)
12/21/2005CN1232250C Andrographolide lactone microcapsule and its preparation method
12/21/2005CN1232249C Application of chalcone for preparing medicines for treating hepatitis
12/20/2005US6977302 useful in treatment of fungal infections in humans and other mammals
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977263 Chemical compounds
12/20/2005US6977243 Crystal forms of azithromycin
12/20/2005US6977176 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance
12/20/2005US6977158 Mammalian IAP gene family, primers, probes, and detection methods
12/20/2005US6977144 Nucleic acids encoding Selected Interacting Domain (SID registered) polypeptides binding selectively to a peptide encoded by a pathogenic strain of the hepatitis C virus; genetic engineering; gene therapy; bactericides;
12/20/2005US6977078 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
12/20/2005US6977076 Immunomoderators; high molecular weight polysaccharides
12/20/2005US6977075 Administering to a patient having a disorder associtaed with an intracellular pathogen, a molecular conjugate of a photosensitizer and a targeting moiety, wherein the targeting moiety targets conjugate to the pathogen or infected cell
12/20/2005US6977074 to an antigen by sustained release to the lymphatic system; cytotoxic T lymphocytes; immunization; drug delivery
12/20/2005US6977072 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005US6977070 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
12/20/2005CA2322432C Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
12/20/2005CA2238516C Acyclic nucleoside derivatives
12/18/2005CA2509049A1 Production of mutant strain of aspergillus fumigatus, method and assay for inhibiting siderophore biosynthesis and diagnostic method for detecting likely aspergillus fumigatus infection
12/18/2005CA2472695A1 Production of mutant strain of aspergillus fumigatus and method and assay for inhibiting siderophore biosynthesis
12/15/2005WO2005118777A2 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
12/15/2005WO2005118613A2 Antibacterial amide macrocycles
12/15/2005WO2005118593A1 Bicyclic heterocycles as hiv integrase inhibitors
12/15/2005WO2005118575A1 Non nucleoside reverse transcriptase inhibitors
12/15/2005WO2005118559A1 A type of formyl peptide receptor-like 1 regulator, preparation method and use thereof
12/15/2005WO2005117961A1 Sars virus vaccine with adenovirus carrier and preparation method thereof , and use of sars virus s gene for preparation of vaccine
12/15/2005WO2005117956A2 Neisserial vaccines
12/15/2005WO2005117904A2 Phosphonate analogs of hiv integrase inhibitor compounds
12/15/2005WO2005117885A1 Use of imatinib to treat liver disorders and viral infections
12/15/2005WO2005117845A1 Oral preparations and process for production thereof
12/15/2005WO2005017124A3 Peptide deformylase inhibitors
12/15/2005WO2002083855A3 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2005US20050277683 Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
12/15/2005US20050277641 Nitrogen compounds such as 4-[[4-[[2,6-dibromo-4-(1-methylethyl)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzonitrile, used for prophylaxis of viral diseases such as human immunodeficiency virus
12/15/2005US20050277630 Antibacterial agents
12/15/2005US20050277620 Aryl phosphate derivatives of d4T
12/15/2005US20050277616 Thymine nucleosides with anti-hepatitis B virus activity
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277589 Linear cationic peptides having antibacterial and/or antifungal properties
12/15/2005US20050277583 Histone deacetylase inhibitors and process for producing the same
12/15/2005US20050277573 Disinfectant
12/15/2005US20050277112 Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050276838 Composition and method for viral inhibition
12/15/2005US20050276821 Antigen protein and nucleic acid coding for said protein
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050276813 Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations
1 ... 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 ... 1798